Case Study: The Value of Independent Quality Oversight for Sponsors

As the FDA is applying increasing pressure on sponsors to validate the work of their CROs, the need for independent quality oversight has become a critical element of the clinical trial process. Beaufort has been at the forefront of recognizing this unique need, and we are the first CRO to offer independent quality oversight services to help sponsors ensure CRO’s are performing according to expectations and commitments as mandated by the FDA.

Read this Case Study to see how Beaufort helped a global pharmaceutical firm that needed in-process oversight of its CROs for a pivotal Phase III trial.

The Value of Independent QO for Sponors

Date posted: November 19, 2015

Categories: Case Studies News and Events Quality Assurance & Compliance